Corentin Languepin

Rex Medical (United States)

Papers

1

Total Citations

2

H-Index

1

About

Corentin Languepin is a pioneering researcher at the intersection of robotics, artificial intelligence, and cardiovascular medicine. His primary research areas include autonomous surgical robotics, AI-guided medical interventions, and transcatheter heart valve implantation (TAVI). Languepin’s major contribution lies in developing and validating the first autonomous robotic system for TAVI procedures, a breakthrough that promises to enhance precision and reduce human error in minimally invasive heart surgery. His landmark 2025 paper, "Towards autonomous robot-assisted transcatheter heart valve implantation: in vivo teleoperation and phantom validation of AI-guided positioning," has already garnered 2 citations, signaling early impact in this nascent field. This work demonstrates successful teleoperation and AI-driven positioning in both animal models and phantom setups, laying the groundwork for clinical translation. Languepin’s achievements are notable for addressing a critical need: as TAVI expands to younger and intermediate-risk patients, the demand for reproducible, highly accurate valve placement grows. By integrating machine learning with robotic control, he is redefining the standard of care for structural heart disease. His research not only advances surgical robotics but also offers a scalable solution to improve outcomes for thousands of patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Towards autonomous robot-assisted transcatheter heart valve implantation: in vivo teleoperation and phantom validation of AI-guided positioning
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Rex Medical (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago